Research Articles | Page 7 | Aplastic Anemia & MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. Jan 2019 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates Jan 2019 Semin Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry Jan 2019 Am J Hematol aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial. Dec 2018 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria. Nov 2018 Hematology Am Soc Hematol Educ Program paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications. Oct 2018 Curr Oncol myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy Jul 2018 Expert Rev Hematol myelodysplastic syndromes (MDS)
Diagnostic algorithm for lower-risk myelodysplastic syndromes Jun 2018 Leukemia myelodysplastic syndromes (MDS)
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care Jun 2018 Leuk Lymphoma myelodysplastic syndromes (MDS)
Iron overload in patients with myelodysplastic syndromes: An updated overview Jun 2018 Cancer myelodysplastic syndromes (MDS)